(19)
(11) EP 4 178 545 A2

(12)

(88) Date of publication A3:
17.02.2022

(43) Date of publication:
17.05.2023 Bulletin 2023/20

(21) Application number: 21838378.4

(22) Date of filing: 12.07.2021
(51) International Patent Classification (IPC): 
A61K 9/127(2006.01)
A61K 39/215(2006.01)
 A61K 39/12(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 2039/55555; A61K 2039/53; A61K 39/12; C12N 2770/20034; A61P 31/14; A61K 2039/575
(86) International application number:
PCT/US2021/041245
(87) International publication number:
WO 2022/011332 (13.01.2022 Gazette 2022/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 10.07.2020 US 202016925438
17.03.2021 US 202117204511

(71) Applicant: Engimata, Inc
Pleasanton, CA 94566 (US)

(72) Inventors:
  • MOSHARRAF, Mitra
    Danville, California 94506 (US)
  • SORAYYA, Aryo
    Danville, California 94506 (US)
  • NAYAR, Rajiv
    Danville, California 94506 (US)

(74) Representative: Horn Kleimann Waitzhofer Patentanwälte PartG mbB 
Ganghoferstraße 29a
80339 München
80339 München (DE)

   


(54) IMMUNOGENIC COMPOSITION FORMING A VACCINE, AND A METHOD FOR ITS MANUFACTURE